KKR is in advanced negotiations to acquire Integer Holdings, a medical device components manufacturer, at a proposed price of $127 per share, according to Wall Street Journal reporting. The stock jumped 21% on the news, reaching a 52-week high of $112.01. The offer price of $127 represents a meaningful premium above where shares were trading before the reports emerged.
When a private equity firm tables a specific per-share price in advanced talks, the stock typically trades up to just below that number as the market prices in deal completion risk. Integer shares are now trading in arbitrage territory, meaning the remaining upside to $127 is the spread investors collect if the deal closes. Anyone holding Integer before this news has a decision to make about locking in gains versus betting on deal completion.
No confirmed deal signing date yet. Watch for an official merger agreement announcement, which would trigger a shareholder vote timeline. Integer's next earnings release would also be a key date if the deal remains unsigned.
Full analysis · Subscribers
The deep dive (bull case, bear case, and the data point that decides which side wins), the cause-and-effect chain behind the move, plain-English explainers for every block.
Aggregated reads dozens of sources in five languages and turns the day into plain-English cards like this one.
Educational analysis of public information, not investment advice. Report an error · Corrections policy
← Today's brief